Mackay Shields LLC’s AngioDynamics ANGO Stock Holding History

Mackay Shields LLC’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,300	Closed	-$217K	–	740
2021 Q1	$217K	Sell	9,300 -6,100	-40%	-$123K	﹤0.01%	1396
2020 Q4	$236K	Buy	+15,400	New	+$195K	﹤0.01%	1391
2020 Q1	–	Sell	-119,300	Closed	-$1.91M	–	1394
2019 Q4	$1.91M	Buy	119,300 +67,200	+129%	+$1.03M	0.01%	889
2019 Q3	$960K	Buy	+52,100	New	+$1.02M	0.01%	1122
2019 Q2	–	Sell	-38,868	Closed	-$888K	–	1403
2019 Q1	$888K	Buy	38,868 +300	+0.8%	+$6.51K	0.01%	1036
2018 Q4	$776K	Buy	38,568 +6,654	+21%	+$138K	0.01%	1016
2018 Q3	$694K	Buy	31,914 +3,400	+12%	+$75.5K	0.01%	950
2018 Q2	$635K	Sell	28,514 -37,800	-57%	-$773K	﹤0.01%	1048
2018 Q1	$1.14M	Buy	+66,314	New	+$1.11M	0.01%	945

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Mackay Shields LLC's ANGO Position: Q2 2021 in Review

Mackay Shields LLC sold out of AngioDynamics (ANGO) in Q2 2021, closing a stake of 9,300 shares — an estimated $217K sold.

Mackay Shields LLC first reported a position in ANGO in Q1 2018 and held it in 9 quarters. The position peaked at $1.91M in Q4 2019. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2021.

Mackay Shields LLC reported no remaining AngioDynamics position as of Q2 2021 after selling out during the quarter.
Mackay Shields LLC sold 9,300 AngioDynamics shares in Q2 2021, an estimated $217K.
Mackay Shields LLC first reported a position in AngioDynamics in Q1 2018 and held it in 9 quarters.
Mackay Shields LLC's AngioDynamics position peaked at $1.91M in Q4 2019.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.